Welcome to our dedicated page for Oracle SEC filings (Ticker: ORCL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Oracle Corporation’s (ORCL) U.S. Securities and Exchange Commission filings, giving investors a primary source of information on the company’s governance, capital structure, and material events. Oracle’s common stock, par value $0.01 per share, is registered under Section 12(b) of the Exchange Act and listed on the New York Stock Exchange under the symbol ORCL, as disclosed in multiple Forms 8‑K.
Among Oracle’s key filings are current reports on Form 8‑K, which document events such as quarterly financial results, cash dividend declarations, leadership and board changes, and significant financing transactions. Recent 8‑K filings describe press releases announcing fiscal quarter results, the declaration of cash dividends on Oracle’s common stock, the promotion of executives to Chief Executive Officer roles and Principal Financial Officer, the appointment and retirement of directors, and the issuance of senior notes under an existing shelf registration statement.
Oracle’s definitive proxy statement on Schedule 14A (DEF 14A) outlines matters for its annual meeting of stockholders, including the election of directors, an advisory vote on executive compensation, and ratification of its independent registered public accounting firm. The proxy statement also discusses board structure, committees, corporate governance guidelines, stock ownership policies, and executive compensation programs.
Investors may also find Form 25 filings relevant for specific Oracle debt securities. Oracle has filed a Form 25‑NSE relating to the removal from listing of its 3.125% Notes due 2025 from the New York Stock Exchange. This filing concerns a class of notes and is separate from the listing of Oracle’s common stock.
On Stock Titan, Oracle’s SEC filings are organized chronologically and can be paired with AI‑powered summaries that explain the purpose and implications of each document. This helps readers quickly understand items such as 8‑K event descriptions, proxy proposals, and capital markets transactions, while still allowing direct access to the full text of Oracle’s submissions to the SEC.
Oracle Corporation is planning a primary offering of senior unsecured notes, including both floating-rate and multiple fixed-rate tranches with maturities ranging from 2029 to 2066. The notes rank equally with Oracle’s existing unsecured, unsubordinated debt and are structurally subordinated to subsidiary liabilities.
Concurrently, Oracle plans a public offering of 100,000,000 depositary shares representing interests in Series D mandatory convertible preferred stock and may sell up to $20 billion of common stock through an at-the-market equity program. Net proceeds from the notes are expected to be used for general corporate purposes, including capital expenditures, debt repayment, investments or acquisitions, and dividends or share repurchases.
Oracle Corporation is offering 100,000,000 Depositary Shares, each representing a 1/2,000th interest in a share of its Series D Mandatory Convertible Preferred Stock. Each preferred share has a $100,000 liquidation preference, so each Depositary Share represents a $50 preference.
Dividends on the preferred stock are cumulative and payable quarterly through January 15, 2029, in cash, stock, or a mix, when declared by the board. Unless converted earlier, each preferred share will automatically convert around January 15, 2029 into a variable number of Oracle common shares based on the average trading price over a 20‑day period before that date.
Oracle is also planning concurrent financing transactions, including a public offering of senior notes and an equity distribution program allowing sales of up to $20 billion of common stock in at‑the‑market transactions. Net proceeds from this preferred offering are earmarked for general corporate purposes such as capital spending, debt repayment, investments, acquisitions, dividends or share repurchases.
Oracle Corporation has filed a post‑effective amendment to its Form S‑3 shelf registration, updating its base prospectus and adding depositary shares as an additional class of registered securities. Under this shelf, Oracle or selling security holders may offer common stock, preferred stock, debt securities, warrants, purchase contracts, units and depositary shares from time to time using prospectus supplements that will spell out specific terms such as interest rates, maturities, redemption features, listing status and conversion or exchange rights.
Oracle states that net proceeds from any primary offerings will be used for general corporate purposes, including capital expenditures, debt repayment, investments or acquisitions, and dividends or share repurchases. The filing also reiterates Oracle’s broad enterprise IT business across cloud, software, hardware and services.
Oracle Corporation executive Stuart Levey reported a routine equity accrual related to his compensation. On 01/23/2026, he received 337.783 restricted stock units as an "A"-coded acquisition. These units represent dividend equivalents accrued on earned restricted stock units originally granted on November 5, 2022, which he has elected to defer. The number of dividend equivalents was calculated using Oracle's closing stock price of $177.16 on the dividend payment date. Following this transaction, Levey beneficially owns 159,494.982 derivative securities in the form of restricted stock units, held directly.
Oracle Corp executive Douglas A. Kehring, EVP and Principal Financial Officer, reported selling 35,000 shares of Oracle common stock on January 15, 2026 at a price of $194.89 per share. The sale was made pursuant to a Rule 10b5-1 trading plan that was adopted on October 9, 2025, which allows pre-arranged trading according to preset terms.
Following this transaction, Kehring reports 33,638 shares of Oracle common stock held directly. He also reports an additional 2,157.514 units of Oracle common stock indirectly through the company’s 401(k) plan, where his interest is represented by units in a common stock fund rather than individual shares.
An Oracle insider filed a notice of proposed stock sales under Rule 144, covering up to 35,000 shares of common stock. The shares are to be sold through Fidelity Brokerage Services on or about 01/15/2026 on the NYSE, with an aggregate market value of $6,821,150.00 based on the figures provided. Oracle had 2,873,130,000 shares of common stock outstanding, giving context for the relative size of this planned sale.
The shares listed for sale were recently acquired through restricted stock vesting from the issuer, including 3,539 shares vested on 09/19/2025 and 31,461 shares vested on 09/20/2025 as compensation. By signing the notice, the selling party represents that they are not aware of any undisclosed material adverse information about Oracle’s current or prospective operations.
Oracle Corporation reported that two long-serving members of its Board of Directors have retired. On January 5, 2026, George H. Conrades, age 86, informed the Board that he is retiring as a director effective immediately after 18 years of service to Oracle. On January 7, 2026, Naomi O. Seligman, age 87, also notified the Board that she is retiring as a director effective immediately after 20 years of service.
Oracle stated that neither retirement was the result of any dispute or disagreement with the company on matters related to its operations, policies or practices, indicating that these departures are described as voluntary retirements following long tenures on the Board.
Oracle Corp executive Mark Hura reported two recent transactions in Oracle stock. On 12/22/2025, he made a bona fide gift of 5,000 shares of common stock to a donor advisory fund. Following that gift, he held 249,077 shares directly. On 12/24/2025, he sold 15,000 shares of Oracle common stock in open-market trades at a weighted average price of $196.8876 per share, with individual trades ranging from $196.87 to $196.93. After this sale, he directly owned 234,077 Oracle shares. Hura is identified as an officer of Oracle, serving as President, Global Field Operations.
An affiliate of Oracle Corporation has filed a notice of proposed sale of restricted stock under Rule 144. The filing covers the potential sale of 15,000 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of $2,953,314.24. The approximate sale date is listed as 12/24/2025.
The shares were acquired as compensation through restricted stock vesting on 09/20/2025 from the issuer. The filing notes that there were 2,873,130,000 shares of this class outstanding at the time referenced, providing context for the relative size of the planned transaction.
Oracle Corporation insider Jeffrey Henley, a director and Vice Chairman, reported a change in how he holds some of his Oracle common stock. On December 23, 2025, he transferred 199,071 shares of common stock from his family trust to the Jeffrey & Judy Henley 1989 Trust. The filing states that he believes this transfer is a change in the form of beneficial ownership that is exempt under Rule 16a-13 of the Securities Exchange Act of 1934.
After the transaction, Henley reported indirect beneficial ownership of 1,200,910 shares by trust, 145,114 shares by a GRAT, and 362,029 shares by the Henley Community Property Trust. The reported transaction price is listed as $0, reflecting that this was a restructuring of ownership between related trusts rather than an open-market trade.